Insider · CIK 0001743658

HALKUFF DAWN

Reports to the SEC for 2 companies · CHICAGO, IL

sec.gov

Transactions

Companies

Filings

CIK

0001743658

Forms 4 and 5

Insider transactions

21 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-04	XERSXeris Biopharma Holdings, Inc.A Award	Director	AAward	+24.2K sh	—	—	119,193
2026-06-04	XERSXeris Biopharma Holdings, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+33K sh	$6.15	+$203K	32,996
2026-06-04	XERSXeris Biopharma Holdings, Inc.S Sale	Director	SSale	−20K sh	$6.09	−$122K	95,000
2025-08-12	XERSXeris Biopharma Holdings, Inc.S Sale	Director	SSale	−42.5K sh	$7.28	−$309K	115,000
2025-06-04	XERSXeris Biopharma Holdings, Inc.A Award	Director	AAward	+50K sh	—	—	157,500
2024-06-05	XERSXeris Biopharma Holdings, Inc.A Award	Director	AAward	+50K sh	—	—	107,500
2023-11-20	XERSXeris Biopharma Holdings, Inc.P Purchase	Director	PPurchase	+5,410 sh	$1.84	+$9,954.4	5,410
2023-06-07	XERSXeris Biopharma Holdings, Inc.A Award	Director	AAward	+42.5K sh	—	—	57,500
2022-06-08	XERSXeris Biopharma Holdings, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2022-06-08	XERSXeris Biopharma Holdings, Inc.A Award	Director	AAward	+15K sh	—	—	15,000
2021-10-05	XERSXeris Biopharma Holdings, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+11.2K sh	—	—	11,228
2021-10-05	XERSXeris Biopharma Holdings, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+19.7K sh	—	—	19,650
2021-10-05	XERSXeris Biopharma Holdings, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2021-10-05	XERSXeris Biopharma Holdings, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+11.2K sh	—	—	11,228
2021-10-05	XERIS PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−19.7K sh	—	—	0
2021-10-05	XERIS PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−20K sh	—	—	0
2021-10-05	XERIS PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−11.2K sh	—	—	0
2021-10-05	XERIS PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−11.2K sh	—	—	0
2021-06-08	XERIS PHARMACEUTICALS INCStock Option (Right to Buy)A Award	Director	AAward	+11.2K sh	—	—	11,228
2020-06-04	XERIS PHARMACEUTICALS INCStock Option (right to buy)A Award	Director	AAward	+11.2K sh	—	—	11,228
2019-02-27	XERIS PHARMACEUTICALS INCStock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000

Recent filings

Accepted (ET)
Jun 54
HALKUFF DAWN0001743658-26-000002
SEC(opens sec.gov)
Aug 134
HALKUFF DAWN0001867096-25-000138
SEC(opens sec.gov)
Jun 44
HALKUFF DAWN0001867096-25-000112
SEC(opens sec.gov)
Jun 54
HALKUFF DAWN0001867096-24-000103
SEC(opens sec.gov)
Nov 214
HALKUFF DAWN0001867096-23-000151
SEC(opens sec.gov)
Jun 74
HALKUFF DAWN0001867096-23-000097
SEC(opens sec.gov)
Jun 94
HALKUFF DAWN0001867096-22-000092
SEC(opens sec.gov)
Oct 54
HALKUFF DAWN0000899243-21-039340
SEC(opens sec.gov)
Oct 54
HALKUFF DAWN0000899243-21-039255
SEC(opens sec.gov)
Jun 84
HALKUFF DAWN0001346302-21-000060
SEC(opens sec.gov)
Jun 44
HALKUFF DAWN0000899243-20-015326
SEC(opens sec.gov)

Companies

Address

C/O XERIS BIOPHARMA HOLDINGS, INC. 1375 WEST FULTON STREET, SUITE 1300

CHICAGO, IL, 60607